Organovo Holdings, Inc.
(NASDAQ : ONVO)

( )
ONVO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Loading ONVO News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.80%69.291.0%$931.38m
AMGNAmgen Inc.
-0.09%173.140.8%$656.50m
BIIBBiogen Inc.
-0.71%286.900.9%$536.61m
CELGCelgene Corporation
-1.42%119.441.0%$479.99m
REGNRegeneron Pharmaceuticals, Inc.
0.12%371.611.9%$348.38m
ALXNAlexion Pharmaceuticals, Inc.
0.83%129.892.0%$299.57m
TSROTESARO, Inc.
-0.05%190.2715.3%$198.98m
INCYIncyte Corporation
1.55%122.362.3%$170.12m
ILMNIllumina, Inc.
-0.75%162.153.9%$148.02m
VRTXVertex Pharmaceuticals Incorporated
-2.02%86.552.6%$140.07m
CLVSClovis Oncology, Inc.
-4.27%62.9916.4%$132.37m
EXELExelixis, Inc.
-0.04%23.115.5%$131.47m
AAgilent Technologies, Inc.
-0.54%51.351.7%$117.26m
ACADACADIA Pharmaceuticals Inc.
-0.20%39.2019.0%$93.83m
BMRNBioMarin Pharmaceutical Inc.
0.41%90.244.0%$89.98m

Company Profile

Organovo Holdings, Inc. is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo Holdings was founded on January 30, 2012 and is headquartered in San Diego, CA.